JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.02B |
| 3 |
Northrop Grumman
NOC
|
+$504M |
| 4 |
Truist Financial
TFC
|
+$493M |
| 5 |
Analog Devices
ADI
|
+$490M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.87B |
| 2 |
Tesla
TSLA
|
+$1.01B |
| 3 |
Verizon
VZ
|
+$808M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$798M |
| 5 |
TSMC
TSM
|
+$797M |
Sector Composition
| 1 | Technology | 17.8% |
| 2 | Consumer Discretionary | 11.45% |
| 3 | Healthcare | 10.78% |
| 4 | Financials | 10.38% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $36.3M | 0.01% |
3,443,465
| – | – |
|
|
IFFT
1002
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $36.2M | 0.01% |
817,727
+91,660
| +13% | +$4.06M |
|
1003
Kinross Gold
KGC
$28.3B
| $36.2M | 0.01% |
4,044,651
+125,951
| +3% | +$1.13M |
|
1004
Nucor
NUE
$33B
| $36.2M | 0.01% |
808,105
+127,241
| +19% | +$5.69M |
|
|
DOC
1005
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $36.1M | 0.01% |
2,022,338
+194,554
| +11% | +$3.48M |
|
|
BKI
1006
DELISTED
Black Knight, Inc. Common Stock
BKI
| $36M | 0.01% |
414,534
+228,197
| +122% | +$19.8M |
|
1007
Church & Dwight Co
CHD
$23B
| $36M | 0.01% |
387,952
-80,970
| -17% | -$7.52M |
|
1008
Robert Half
RHI
$3.7B
| $36M | 0.01% |
684,271
+551,527
| +415% | +$29M |
|
1009
PENN Entertainment
PENN
$2.92B
| $35.8M | 0.01% |
516,114
+129,666
| +34% | +$9M |
|
1010
Stifel
SF
$11.8B
| $35.7M | 0.01% |
1,068,050
+43,299
| +4% | +$1.45M |
|
1011
TTM Technologies
TTMI
$4.99B
| $35.5M | 0.01% |
3,093,548
-2,125,671
| -41% | -$24.4M |
|
1012
Zai Lab
ZLAB
$3.61B
| $35.5M | 0.01% |
429,976
+203,031
| +89% | +$16.8M |
|
|
GBT
1013
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $35.4M | 0.01% |
656,435
-85,599
| -12% | -$4.62M |
|
1014
Ionis Pharmaceuticals
IONS
$10.2B
| $35.3M | 0.01% |
727,929
+209,760
| +40% | +$10.2M |
|
1015
JFrog
FROG
$5.82B
| $35.3M | 0.01% |
+412,817
| New | +$35.3M |
|
|
DCP
1016
DELISTED
DCP Midstream, LP
DCP
| $35.2M | 0.01% |
3,077,742
+1,397,101
| +83% | +$16M |
|
1017
Acadia Pharmaceuticals
ACAD
$4.08B
| $35.1M | 0.01% |
869,842
-206,713
| -19% | -$8.35M |
|
1018
Marvell Technology
MRVL
$57.4B
| $34.7M | 0.01% |
880,600
+84,141
| +11% | +$3.32M |
|
1019
CRISPR Therapeutics
CRSP
$5.08B
| $34.6M | 0.01% |
406,815
+159,481
| +64% | +$13.6M |
|
1020
TotalEnergies
TTE
$134B
| $34.5M | 0.01% |
1,035,755
+877,076
| +553% | +$29.2M |
|
1021
Tyson Foods
TSN
$20B
| $34.5M | 0.01% |
584,669
+95,983
| +20% | +$5.66M |
|
1022
Xylem
XYL
$34.5B
| $34.3M | 0.01% |
409,376
+105,356
| +35% | +$8.83M |
|
1023
American Well
AMWL
$109M
| $34.1M | 0.01% |
+60,759
| New | +$34.1M |
|
|
STOR
1024
DELISTED
STORE Capital Corporation
STOR
| $34.1M | 0.01% |
1,253,090
+46,284
| +4% | +$1.26M |
|
|
JKS
1025
JinkoSolar
JKS
$1.22B
| $34.1M | 0.01% |
867,610
+213,328
| +33% | +$8.37M |
|